PHARMACY

Quest Diagnostics brings patient-initiated screenings to Colo., Mo.

BY David Salazar
MADISON, N.J. — Quest Diagnostics on Monday expanded ts new patient-initiated testing services to Colorado and Missouri, allowing patients to order lab tests without a physician’s order. Among the tests available are lipid panels, STI and HIV screenings and diabetes risk and management panels. 
 
"In today's consumer-driven health care environment, people want to play a more active role in managing their own health and wellness, and our Patient-Initiated Testing service is another resource for individuals to empower better health," Quest Diagnostics president and CEO Steve Rusckowski said. "Consumers expect the most accurate and up-to-date diagnostic information to proactively manage their health so that they can make educated decisions, and we are pleased to begin offering this service to residents of Colorado and Missouri."
 
Quest’s labs are accredited by the College of American Pathologists and patients will be able to access results from their screenings via MyQuest by Care360. The rollout of direct access for Colorado and Missouri patients follows Quest’s efforts in Arizona and Oklahoma that made lab testing accessible through joint venture partners, as well as the rollout of laboratory testing services to 12 Safeway locations in five states. 
 
"We are pleased to offer consumers a responsible menu of tests that will give them the insight about their health and well-being," Quest SVP and group executive, clinical franchise solutions Cathy Doherty, said. "We believe that consumer engagement in personal health is critical and we aim to ensure consumers are connected to high quality medical care – when and where they need it."
 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Smith Drug names new VP long-term care

BY David Salazar
SPARTANBURG, S.C. —  Smith Drug Co. has named Jeff Schneider as its VP long-term care pharmacy solutions, the company announced Monday. As the head of the newly dedicated department, Schneider will be responsible for developing solutions for the new and existing long-term care customers. 
 
“We’re not new to the LTC market,” Smith Drug president Jeff Foreman said. ”We have great relationships with many customers. They’ve been telling us what they’d like to see, what’s not really offered by any one provider in the industry, and we’ve listened. We’ve brought an LTC expert on board — someone specifically tasked with providing expertise to our customers and helping them grow their business. Jeff has a wealth of knowledge and experience, and we are excited to have him lead the LTC team.”
 
As a pharmacist, Schneider has been involved with LTC pharmacy for more than 20 years, holding executive roles with such companies as NeighborCare and Omnicare, with professional experience with start-up, turnaround, multi-site and multi-state LTC pharmacy. With his new role on Smith Drug’s leadership team, Schneider will work to help customers grow their businesses. 
 
“I’ve been where our customers are. I know the pressure to provide excellent patient care, while maintaining a solid business strategy and compliance with ever-changing regulations,” Schneider said. “I have first-hand experience that no other vendor can match the excellent customer service provided by Smith Drug Co. I am excited that my new role will be leading a team that can offer customers solutions that are simply not found anywhere else. Of course that includes wholesale distribution, but in addition to that, we can provide consultation on how to open, expand and improve operations. We can help our customers increase their success.”
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Pfizer Global Supply president Maddaluna to retire

BY David Salazar
NEW YORK — Anthony Maddaluna, Pfizer EVP, president of Pfizer Global Supply and a 41-year company veteran will be retiring, Pfizer announced Monday. Maddaluna will be succeeded by Kirsten Lund-Jurgensen, effective Dec. 30. 
 
“I have had the privilege of working with Tony during much of his career, and he has been a valuable partner to me,” Pfizer chairman and CEO Ian Read said. “Tony has continually demonstrated a steadfast commitment to Pfizer and our mission. His focus on quality, compliance and customer service has established Pfizer Global Supply as an industry leading supply organization that is highly respected by internal and external stakeholders. I know I join all Pfizer colleagues in thanking Tony for his tireless efforts and wishing him and his family all the best as 
 
Maddaluna began working at Pfizer in 1975 and has held several positions with increasing responsibilities since then, eventually being named president of Pfizer Global Supply in 2011. 
 
“I have thoroughly enjoyed my career at Pfizer and being part of the company’s executive leadership team,” Maddaluna said. “Based on more than four decades at Pfizer, I am truly proud of our dedicated colleagues who have discovered, developed and delivered the high quality vaccines and medicines that combat the world’s most pressing healthcare challenges today.”
 
Lund-Jurgensen joined Pfizer in 1999 as VP global supply chain management, pharmaceuticals. Prior to that she was with SmithKline Beecham in Germany, Australia and the United States, serving in various operational roles. She is a pharmacist with a Ph. D. in pharmaceutical biology from Germany’s Freiburg University. 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES